Navigation Links
Asoyia Announces New Mid Oleic Ultra Low Lin Soybean Oil
Date:2/12/2008

Asoyia-MO is the first and only soybean oil to provide the highest level of

stability, zero trans fats per serving, and light, clean taste.

IOWA CITY, Iowa, Feb. 12 /PRNewswire/ -- An Iowa-based soybean oil producer is introducing a new product that not only meets the increasing consumer demand for low trans fat foods, but also maintains an elevated degree of stability and neutral taste so important to food processors.

Asoyia Mid Oleic Ultra Low Lin Oil (Asoyia-MO) is made from soybeans containing high oleic content with less than 1% linolenic acid, keeping the oil fresh and shelf-stable for two to three times longer and eliminating the need for high trans fat-generating hydrogenation.

Beth Fulmer-Boyer, Asoyia vice president of sales, said food scientists will benefit from using Asoyia-MO in applications requiring longer shelf and fryer life, while providing a healthier alternative to more commonly used hydrogenated oils. As an added advantage, Asoyia-MO is made from soybean oil, often the preferred ingredient for its neutral taste.

"There is no question in my mind that whoever tries it will like it. The question for food processors is, do you need the increased stability, clean mouth feel, and low trans fats for your product, and is there a value associated with it?" Fulmer-Boyer explained.

Companies producing natural products, or shipping product overseas, should note that Asoyia-MO is produced from non-genetically modified soybeans. Regulations against the use of genetically modified ingredients in other countries require many companies to maintain separate manufacturing runs or ingredient inventories. Asoyia-MO would help alleviate those costly needs.

Asoyia-MO is the new generation of Asoyia Ultra Low Lin Oil (Asoyia-ULL), which was introduced to the market in 2004. Asoyia-ULL is made from 1% linolenic soybeans, making it the only commercially produced choice in the ultra low lin soybean oil category. Other low lin soybean oils on the market contain at least 3% linolenic acid, or three times the linolenic acid in Asoyia-ULL and Asoyia-MO.

Terri Volpe, Asoyia's technical advisor, described Asoyia-ULL as a readily available solution for tough formulations requiring a high degree of stability and zero trans fats per serving. "Asoyia-MO is the next step. It goes the extra mile for stability," she explains.

Asoyia-MO is in the early stages of production, available in small commercial quantities for processors interested in testing and evaluating it in their applications. For more information about Asoyia products and product testing, visit http://www.asoyia.com or call toll free 877-ASOYIA1.

Formed in 2004 by 25 Iowa farmers, Asoyia is now a farmer- and employee-owned company based in Iowa City, Iowa that grows and processes 1% ultra low linolenic soybeans to produce trans fat-free oils. The research, testing and expansion of Asoyia's soybean genetics dates back to the 1960s at Iowa State University, where Dr. Walt Fehr and his team developed the specialty soybean.

FOR MORE INFORMATION:

Andrea James

Office: (515)223-1383

Cell: (515) 473-2823

andrea@bigfoodideas.com


'/>"/>
SOURCE Asoyia
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2017)... , ... August 20, 2017 , ... ... HIPAA ComplyPAK™ Compliance Management System has assisted multiple clients in successfully ... Public Accountants, Service Organization Control Level 2 (AICPA SOC Level 2), and State ...
(Date:8/19/2017)... ... August 19, 2017 , ... ... will feature the Aurum Group in an upcoming episode, slated to air fourth ... Innovations will feature the Aurum Group; a company committed to supporting dentistry using ...
(Date:8/19/2017)... ... August 18, 2017 , ... ... Act of 2017, legislation that provides for greater public access to over-the-counter (OTC) ... loss to access OTC hearing aids without being seen by a certified and ...
(Date:8/19/2017)... ... August 19, 2017 , ... Praeclarus Press has launched a ... show the diversity of the breastfeeding mothers, using bright colors and contemporary ... These illustrations are also available on tote bags, notepads, smartphone cases, clocks, and ...
(Date:8/19/2017)... ... August 19, 2017 , ... Physician ... its Orlando location as an interventional pain management physician. He brings a wealth ... treatment of migraine headaches, and significant experience in spinal cord stimulation for chronic ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... Aug. 7, 2017 Diplomat Pharmacy, Inc. (NYSE: ... Saban as president, effective Aug. 7, 2017. ... decided to pursue other interests and will serve as president ... Paul has served us in multiple leadership roles since he ... Jun. 2015 and has provided decisive, strategic leadership which continues ...
(Date:8/7/2017)... 2017  Endo International plc (NASDAQ: ENDP ... virtually all known U.S. mesh product liability claims and ... known remaining U.S. claims at reasonable values. Under the ... fourth quarter of 2017 and continuing through the fourth ... 2017 results, the Company intends to increase its mesh ...
(Date:8/4/2017)... CINCINNATI , Aug. 3, 2017  Agragen, ... science company active in the biopharmaceutical, nutraceutical, and ... its development of its lead drug candidates, AGR131.  ... a proinflammatory cytokine from the blood of patients ... psoriasis, and inflammatory bowel disease. ...
Breaking Medicine Technology: